These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 116248)

  • 1. Dopaminergic mechanisms and stereotyped behaviour in birds.
    Nistico' G; Stephenson JD
    Pharmacol Res Commun; 1979 Jul; 11(7):555-70. PubMed ID: 116248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selective dopaminergic regulation of stereotyped forms of aggressive and defensive behavior].
    Podol'skiĭ IIa
    Biull Eksp Biol Med; 1977 Apr; 83(4):432-4. PubMed ID: 558022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway.
    Reavill C; Leigh N; Jenner P; Marsden CD
    Exp Brain Res; 1979 Oct; 37(2):309-16. PubMed ID: 315328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between gnawing compulsion and central dopaminergic mechanism in guinea pigs (author's transl)].
    Uemura H
    Nihon Yakurigaku Zasshi; 1979 Jan; 75(1):61-72. PubMed ID: 571393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat.
    Pycock C
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):15-22. PubMed ID: 560634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
    Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anatomical substrate of the turning behaviour seen after lesions in the nigrostriatal dopamine system.
    Garcia-Munoz M; Patino P; Wright AJ; Arbuthnott GW
    Neuroscience; 1983 Jan; 8(1):87-95. PubMed ID: 6300729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):53-61. PubMed ID: 1099605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration.
    Klawans HL; Margolin DI; Dana N; Crosset P
    J Neurol Sci; 1975 Jul; 25(3):283-9. PubMed ID: 1171935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rapid and prolonged facilitation of stereotyped motor behavior (verticalization) induced by apomorphine in mice previously submitted to stimulation of dopaminergic receptors].
    Costentin J; Marçais H; Protais P; Schwartz JC
    C R Acad Hebd Seances Acad Sci D; 1976 Mar; 282(9):913-6. PubMed ID: 820479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopaminergic agents and circling behaviour.
    Dankova J; Bédard P; Langelier P; Poirier LJ
    Gen Pharmacol; 1978; 9(5):295-302. PubMed ID: 212346
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen.
    Costall B; Naylor RJ; Cannon JG; Lee T
    J Pharm Pharmacol; 1977 Jun; 29(6):337-42. PubMed ID: 18569
    [No Abstract]   [Full Text] [Related]  

  • 15. Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems.
    Randrup A; Mogilnicka E
    Pol J Pharmacol Pharm; 1976; 28(6):551-6. PubMed ID: 1034919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurophysiologic and pharmacologic evidence of autoregulationin the nigrostriatal system].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Feb; 91(2):133-6. PubMed ID: 7194700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-dopa causes an acute, partial and reversible reversal of denervation-induced supersensitivity of striatal dopaminergic receptors.
    Ferre S; Casas M; Cobos A; Garcia C; Jane F; Grau JM
    Psychopharmacology (Berl); 1987; 91(2):254-6. PubMed ID: 3107042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
    Kuschinsky K
    Psychopharmacologia; 1975 Jun; 42(3):225-9. PubMed ID: 1172252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD; Creese I
    Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence that apomorphine and (+)-amphetamine produce different types of circling in rats.
    Cools AR; Scheenen W; Eilam D; Golani I
    Behav Brain Res; 1989 Aug; 34(1-2):111-6. PubMed ID: 2765168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.